Allergy Immunotherapy Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Allergy immunotherapy, also referred to as desensitisation or hypo-sensitization, is a medical treatment for allergies of various types. Allergies are becoming more prevalent, and conventional treatments, such as pharmacotherapy, have been proven to be unsuccessful in several instances. As a result, allergy immunotherapy, also known as hypo-sensitization or desensitisation, is gaining popularity as a treatment for a variety of allergies by increasing immunological tolerance and altering disease progression.

MARKET SCOPE

The "Global Allergy Immunotherapy Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the allergy immunotherapy market with detailed market segmentation by treatment, allergy type and distribution channel. The report provides key statistics on the market status of the leading allergy immunotherapy market players and offers key trends and opportunities in the market.MARKET SEGMENTATION

•   Based on treatment the market is segmented as, subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
  
•   Based on allergy type the market is segmented as, asthma, food allergy, allergic rhinitis, venom allergy and others.
  
•   Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies & drug stores and online pharmacies.
  

MARKET DYNAMICS
Drivers:

•   Increasing prevalences of allergies is the key market driver for allergy immunotherapy market.
  
•   Increasing awarness among people for treatment of various kinds of allergies.
  
•   R&D investments by pharmaceutical companies to develop therapies for treatment of allergies.
  

Restraints:

•   However, the unknown pathogenesis and etiology of some allergies is expected to restrain market growth during forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The allergy immunotherapy market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the allergy immunotherapy market in these regions.

IMPACT OF COVID-19 ON ALLERGY IMMUNOTHERAPY MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Allergy Immunotherapy Market Report Analysis

Allergy Immunotherapy Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Merck KGaA
• DBV Technologies
• ALK
• Allergy Therapeutics
• HAL Allergy B.V.
• Aimmune Therapeutics
• Circassia
• asitbiotech-corporate.com
• Stallergenes Greer

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Treatment

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

By Allergy Type

• Asthma
• Food Allergy
• Allergic Rhinitis
• Venom Allergy

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies and Drug Stores
• Online Pharmacies

MARKET PLAYERS

The report covers key developments in the allergy immunotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from allergy immunotherapy market are anticipated to lucrative growth opportunities in the future with the rising demand for allergy immunotherapy in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the allergy immunotherapy market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  Merck KGaA

  DBV Technologies

  ALK

  Allergy Therapeutics

  HAL Allergy B.V.

  Aimmune Therapeutics

  Circassia

  asitbiotech-corporate.com

  Stallergenes Greer

  Adamis Pharmaceuticals Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Allergy Immunotherapy Market Report Scope

Report Attribute	Details
Market size in 2023	US$ XX Million
Market Size by 2031	US$ XX Million
Global CAGR (2023 - 2031)	XX%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Treatment Subcutaneous Immunotherapy Sublingual Immunotherapy By Allergy Type Asthma Food Allergy Allergic Rhinitis Venom Allergy By Distribution Channel Hospital Pharmacies Retail Pharmacies and Drug Stores Online Pharmacies
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Merck KGaA DBV Technologies ALK Allergy Therapeutics HAL Allergy B.V. Aimmune Therapeutics Circassia asitbiotech-corporate.com Stallergenes Greer